ウラシルブイヲユウスルセイブツユウキキンゾクカゴウブツニオケルキンゾクカンソウゴサヨウノコウゾウテキセイギョ by サカモト, ユウキ & 坂本, 勇樹
Osaka University
Title Structural Control of Metal-Metal Interaction inBioorganometallic Compounds Bearing Uracil Moieties
Author(s)坂本, 勇樹
Citation
Issue Date
Text VersionETD
URL http://hdl.handle.net/11094/55966
DOI
Rights
 Doctoral Dissertation 
 
Structural Control of Metal-Metal Interaction 
in Bioorganometallic Compounds Bearing Uracil Moieties 
 
 
 
 
Yuki Sakamoto 
 
 
April 2015 
 
Department of Applied Chemistry 
Graduate School of Engineering, 
Osaka University 
 
  
 
 
 
  
Structural Control of Metal-Metal Interaction 
in Bioorganometallic Compounds Bearing Uracil Moieties 
 
（ウラシル部位を有する生物有機金属化合物における 
金属間相互作用の構造的制御） 
 
 
 
2015 
 
Yuki Sakamoto 
 
Department of Applied Chemistry 
Graduate School of Engineering, 
Osaka University 
 
  
 
 
 
 
 
 
 
Preface 
 
The studies presented in this thesis were performed under the guidance of 
Professor Toshikazu Hirao, Department of Applied Chemistry, Graduate School of 
Engineering, Osaka University during 2009-2015. 
The objects of this thesis are studies on controlling the metal-metal interaction of 
bioorganometallic compounds bearing uracil moieties as nucleobases.  
The author hopes that this basic work described in this thesis contributes to the 
further development of bioorganometallic compounds, structural control of 
organometallic complexes, and so on. 
 
 
 
Yuki Sakamoto 
 
 
Department of Applied Chemistry 
Graduate School of Engineering 
Osaka University 
Suita, Osaka 
Japan 
 
April, 2015  
Contents 
 
  
General Introduction 1 
Chapter 1. Controlled arrangement of organoplatinum(II) complexes 
bearing uracil moieties by using scaffold molecules 
10 
Chapter 2. Synthesis and structural properties of mononuclear 
organogold(I) complexes bearing uracil moieties 
35 
 
Chapter 3. Induced Au(I)-Au(I) interaction of dinuclear organogold(I) 
complexes with diphosphine ligands and uracil moieties  
48 
 
Conclusion  67 
List of Publication  70 
Acknowledgement  71 
 
 
1 
 
General Introduction 
The structural control of molecular self-organization leads to the development 
of functional materials.
1 
Non-covalent bond is useful for the formation of 
self-assembling structures. Control of hydrogen bonding
2
 plays an important role in the 
design of diverse molecular assemblies because of its directionality and specificity.
3
 
Reversibility and tuneability of hydrogen bonding are also significant to affect the 
chemical and/or physical properties of molecular assemblies. 
On the other hand, highly organized molecular aggregates are constructed in 
biosystems to accomplish unique functions as shown in enzymes, receptors, etc. 
Biomolecules such as nucleobases, peptides, and sugars play an important role in the 
formation of the highly organized structures like DNA, proteins, and enzymes. For 
example, the double helical DNA is composed of adenine-thymine and guanine-cytosine 
base pairs, which are managed mainly by complementary hydrogen bondings, - 
interactions, and hydrophobic interactions.
4
 Nucleobases possess a particular ability to 
perform directionally controlled multiple and complementary hydrogen bondings. The 
utilization of nucleobases in bio-inspired systems provides the flexibility to exploit four 
different binding motifs. The employment of self-assembling properties of nucleobases 
is considered to be an appropriate strategy for a design of well-defined molecular 
aggregates.
5
  
 
 
 
2 
 
 
Figure 1. Watson-Crick-like nucleobase pairing and an aggregation system by using 
nucleobases 
 
Uracil is one of major nucleobases and used 
in RNA instead of thymine in DNA. Uracil consists 
of pyrimidine ring and possesses alternately adjacent 
two hydrogen bond donors (D) and two hydrogen 
bond acceptors (A) (Figure 2). Owing to the order of 
acceptor-donor-acceptor (ADA) of hydrogen bonds, uracil can form three hydrogen 
bonds with DAD-typed hydrogen bonding sites. 2,6-diamidopyridine derivatives which 
have DAD-typed hydrogen bonding sites are adopted as the complementary hydrogen 
bonding moieties for uracil in construction of organized-assembling structures by using 
of uracil. For example, Lehn’s group reported formation of supramolecular liquid 
crystalline polymers through the complementary three hydrogen bonds between uracil 
with a 2,6-diamidopyridine derivative (Figure 3a).
6
 Inouye’s group also published 
molecular recognition of thymine by using a scaffold bearing a 2,6-diamidopyridine 
derivative and a conjugate compound (Figure 3b).7 A functional moiety can also be 
introduced to uracil in both fifth and sixth positions of the pyrimidine ring unlike 
Aggregations by
Hydrogen Bonds
Adenine, Thymine, Uracil
Guanine, Cytosine,
Interaction of 
functional Moieties
Scaffold
Nucleobases
Hydrogen Bonds
π-π interaction3.3 Å
Figure 2. Structure of uracil 
3 
 
thymine. Orientation of hydrogen bonds for the functional moiety can be regulated by 
the position of introduction. The above mentioned properties of uracil are useful for 
controlled arrangement of the functioned moieties. 
 
 
Figure 3. (a) Supramolecular liquid crystalline polymers and (b) molecular recognition 
of a thymine derivative by using a scaffold through the complementary hydrogen bonds. 
 
Organometallic compounds have attracted much attention in not only synthetic 
organic chemistry but materials science because of utility of photochemical and 
catalytic abilities and redox properties. The control of the structural properties of metal 
centers is significant to manage the functions of the complexes. It is known that 
metal-metal interaction in the organometallic compounds affects the functions of the 
complexes as catalysis, emission property etc. In particular, square-planar d
8
 transition 
metals and linear geometric d
10
 transition metals exhibit a unique emission and catalytic 
properties based on induced metal-metal interaction owing to stacking of planar or 
linear complexes. However, it is a problem that a multi-step synthesis is necessary for 
an organometallic complex induced the metal-metal interaction.  
 
 
 
(b)(a)
4 
 
Square-planar d
8
 transition metal complexes have intriguing photochemical 
properties. In particular, platinum(II) complexes with oligopyridine or cyclometalating 
ligands have drawn much attention due to their interesting luminescence properties 
based on Pt(II)Pt(II) interaction.8 Emission properties of phenylbipyridine type 
platinum(II) complexes were reported to be changed by the Pt(II)-Pt(II) interaction 
(Figure 4). For instance, Wai-Yeung Wong and co-workers have published the change of 
emission properties through the control of a distance of two platinum(II) moieties based 
on electrostatic interaction between the ligands (Scheme 1a).
9
 Hirao’s group has also 
reported the switching of emission properties based on conformational change of the 
dinuclear platinum(II) complex depending on the solvent polarity(Scheme 1b).
10 
 
 
 
Figure 4. Diagrams of metal-metal-to-ligand charge transfer through Pt(II)Pt(II) 
interaction of phenylbipyridine-typed platinum(II) complexes 
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Scheme 1. 
 
A organogold(I) complex, which is a linear geometric d
10
 transition metal, has 
drawn increasing attention because of aggregation properties through attractive 
aurophilic interaction.
11
 This aurophilic interaction is comparable to the strength of 
hydrogen bonding and convenient for construction of supramolecular architectures in a 
solid state (Figure 5). Gold(I) alkynyl compounds have also attracted attention in a 
variety of areas due to their diverse and interesting photophysical
12
 and biological
13
 
properties. In 1993, Shie-Ming Peng and co-workers reported the emission of a gold(I) 
alkynyl compound based on Au(I)-Au(I) interaction in a solid state.
12a 
 
Figure 5. Diagram of Au(I)-Au(I) interaction 
(a)
(b)
6 
 
The introduction of functional complexes into highly-ordered biomolecules is 
considered to be a convenient approach to design novel biomaterials and bio-inspired 
systems. Recently, the research field of bioorganometallic chemistry, which is a hybrid 
area between organometallic chemistry and biochemistry, has received extensive 
interest.
14
 The combination of functional organometallic compounds with biomolecules 
such as nucleobases and peptides is envisioned to afford bioorganometallic compounds. 
The bioorganometallic compounds are expected to be applicated for probes, catalysts 
and medicines owing to synergistic effect of both properties of organometallic 
compounds and biomolecules. For example, Richard H. Fish and co-workers, Gérard 
Jaouen and co-workers, and Gerard van Koten and co-workers reported the synthesis of 
a rhodium complex bearing guanosine,
15
 a chromium complex bearing an estradiol 
derivative,
16
 and a platinum complex bearing valine
17
 respectively (Figure 6a-c). Hirao’s 
group has also published the formation of a chiral organized structure of ferrocene 
bearing dipeptides through intermolecular hydrogen bonds of the dipeptides (Figure 
6d).
18
 
 
Figure 6. Bioorganometallic compounds composed of organometallic and biomolecular 
moieties such as nucleobase, amino acid and peptide.  
7 
 
From these points of view, a combination of organoplatinum(II) and gold(I) 
complexes with uracils as nucleobases is allowed to design novel bioconjugates and 
controlled arrangement of metal centers depending on both properties. Uracil is useful 
for the construction of supramolecular systems due to its hydrogen bonding capacity, 
which forms complementary hydrogen bonds for 2,6-diamidopyridine derivatives. 
Arrangement of the metal centers by application of assembly property of the uracils is 
convenient for induction of the metal-metal interaction. On the other hand, ancillary 
ligands of the complexes play an important role in aggregation of metal centers. Steric 
hinderance and  interaction of the ancillary ligands affect the assembly properties of 
the organometal-uracil conjugates. 
 
The dissertation deals with studies on syntheses of organoplatinum(II) and 
organogold(I) complexes bearing the uracil moieties and structural control of 
metal-metal interaction through molecular scaffolds and ancillary ligands. 
Chapter 1 describes synthesis of organoplatinum(II)-uracil conjugates and 
controlled arrangement of the platinum(II)complexes by using molecular scaffolds.  
Chapter 2 describes syntheses of organogold(I)-uracil conjugates and 
evaluation of steric effect of ancillary ligands for assembly properties of the gold(I) 
centers.  
Chapter 3 describes syntheses of dinuclear organogold(I)-uracil conjugates 
with bridging diphosphine ligands and induced Au(I)-Au(I) interaction. 
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Chapter 1. Controlled arrangement of organoplatinum(II) 
complexes bearing uracil moieties by using molecular scaffolds 
 
1-1. Introduction 
 As mentioned in general introduction, square-planar d
8
 transition metal 
complexes possess the intriguing photophysical and photochemical properties. In 
particular, luminescent platinum(II) complexes with oligopyridine and cyclometalating 
ligands have attracted much attention. It is reported that the luminescent platinum(II) 
complexes with a phenylbipyridine ligand exhibited an interesting luminescence 
properties based on metallophilic interaction through dZ
2•••dZ
2
 and/or - interactions.1 
On the other hands, uracil is useful for construct of supramolecular systems due to its 
hydrogen bonding capacity. Uracil formed a complementary hydrogen bonds for 
2,6-diamidopyridine derivatives and have two position for introduction of a functional 
moiety.
2
 From these points of view, I report the syntheses of the bioorganometallic 
compounds by conjugation of the uracils and the organoplatinum(II) compounds and 
controlled emission properties based on the regulation of aggregation of platinum(II) 
centers in the chapter 1 (Figure 1). 
 
Figure 1. Design of the bioorganometallic compounds composed of uracils and 
organoplatinum(II) complexes, and molecular scaffolds. 
Scaffolds
4.9 Å
2.5 Å
5
6
Uracil2,6-diamide
pyridine
Pt(II) complex
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1-2. Results and discussion 
1-2-1. Syntheses and structural properties of organoplatinum(II) complexes 
bearing uracil moieties 
The bioorganometallic platinum(II) compounds U6Pt and U5Pt were obtained 
by the treatment of [4-octyloxy-(C^N^N)PtCl] (2), which was prepared from the 
reaction of 6-(4-octyloxyphenyl)-2,2'-bipyridine (1) and K2PtCl4, with 
6-ethynyl-1-octyluracil or 5-ethynyl-1-octyluracil, respectively (Scheme 1). 
 
Scheme 1. 
12 
 
Structural information was found by a single-crystal X-ray structure 
determination. The formation of the dimeric structure through intermolecular hydrogen 
bonds between the uracil moieties of two independent molecules was exhibited in the 
crystal structure of U6Pt (Figure 2a and Table 1). The [4-octyloxy-(C^N^N)Pt] moiety 
is nearly parallel to the uracil moiety probably due to the d,-conjugation; the dihedral 
angles between the least squares plane of the [4-octyloxy-(C^N^N)Pt] and the uracil 
moieties are 19.8(3) and 14.8(3)°. Furthermore, a packing structure of U6Pt revealed 
that each hydrogen-bonded dimer were connected through - interactions between the 
[4-octyloxy-(C^N^N)Pt] ligands as well as uracil moieties to form -stacks. Pt(II)-Pt(II) 
interaction (the intermolecular Pt-Pt distance is ca. 3.3 Å) was observed, as shown in 
Figure 2b.  
 
 
Figure 2. (a) A dimer structure of U6Pt through intermolecular hydrogen bonds 
between the uracil moieties and (b) a portion of a packing structure of U6Pt layer 
containing the -stack molecular assembly through - interactions between the 
[4-octyloxy-(C^N^N)Pt] ligands as well as uracil moieties. 
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Table 1. Intermolecular hydrogen bonds for U6Pt
a
 
Donor Acceptor D•••A (Å) DH•••A (°) 
    N(4) O(23)
b
 2.787(10) 175(5) 
N(24)
b
 O(3) 2.819(10) 170(4) 
N(24) O(3)
b
 2.819(10) 170(4) 
N(4)
 b
 O(23) 2.787(10) 175(5) 
    (a) Two independent molecules exist in an asymmetric unit. 
(b) X+2, Y+1, Z+1. 
  
 
This - and Pt(II)-Pt(II) interactions might require the orientation of the 
[4-octyloxy-(C^N^N)Pt] moiety within a limited range of location parallel to the uracil 
moiety. In fact, the platinum(II) complex U6Pt showed the emission band around 720 
nm, ascribed to the triplet metal-metal-to-ligand charge transfer (
3
MMLCT) excited 
state resulting from Pt(II)-Pt(II) and - interactions, in a solid state (Figure 3). In 
contrast, the platinum(II) complex U5Pt, wherein the direction of hydrogen bonding 
sites of the uracil moieties is different from U6Pt, exhibited an emission band based on 
the metal-to-ligand charge transfer (MLCT) and/or ligand-to-ligand charge transfer 
(LLCT) transition. Synergistic effects of emission properties are considered to depend 
on the aggregation properties of the platinum(II) complexes. 
14 
 
 
Figure 3. Emission spectra (ex = 470 nm) of U6Pt and U5Pt in solid states at 298 K. 
 
1-2-2. Controlled arrangement of organoplatinum(II) complexes bearing uracil 
moieties by using molecular scaffolds 
 
To control the aggregate of the organoplatinum(II) complexes having uracil 
moieties, molecular scaffolds ND and AD combined aromatic rigid frameworks, 
naphthalene and anthracene, respectively, with two 2,6-dihexamidopyridine moieties as 
a complementary hydrogen bonding site for the uracil moiety were designed and 
synthesized as shown in Schemes 2 and 3. The coupling reaction of 
1,8-diiodonaphthalene with 2,6-dihexamido-4-ethynylpyridine (7) afforded the 
molecular scaffold ND by using the palladium-catalyzed Sonogashira coupling 
procedure in 40% yield. The molecular scaffold AD was prepared by the coupling 
reaction of 1,8-diethynylanthracene and 4-(2,6-dihexamidopyridyl) 
trifluoromethanesulfonate (5) in 28% yield.  
 
 
15 
 
 
 
 Scheme 2. 
 
 
 
Scheme 3. 
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In a case of addition of 0.5 molar equiv. amounts of ND to a dichloromethane 
solution of U6Pt, a new shoulder band at around 500 nm was found in the UV/vis 
spectrum as shown in Figure 4a. The absorption at around 500 nm is probably attributed 
to the MMLCT transition based on the aggregation of U6Pt through the complementary 
hydrogen bondings to ND. The emission spectrum of only U6Pt in dichloromethane 
exhibited emission band at 590 nm, which is assigned to a 
3
MLCT and/or 
3
LLCT 
emission (Figure 4b). Interestingly, U6Pt showed a new emission band based on 
synergistic effect around 730 nm with decrease of the 
3
MLCT/
3
LLCT emission in the 
presence of the molecular scaffold ND (Figure 4b). This emission band is assignable to 
a 
3
MMLCT emission based on Pt(II)-Pt(II) and - interactions between the 
[4-octyloxy-(C^N^N)Pt] and uracil moieties as shown in Figure 4b. The molecular 
scaffold ND was found to facilitate aggregation of U6Pt through the complementary 
hydrogen bonding and π-π interaction between the ligands in a solution state. The 1:2 
stoichiometry of ND-U6Pt was verified by Job’s plots. The stepwise association 
constants (K1 and K2 in M
1
) were evaluated to be logK1 = 3.7(3) and logK2 = 4.1(2), 
respectively, for 1:2 complexation of ND with U6Pt.
3
 The value for the ratio 4K2/K1 = 
~16 clearly indicates the positive homotropic cooperative nature of this complexation. 
The metallophilic and - interactions are likely to induce the positive 
cooperative effect. In the case of using U5Pt, such absorption and emission resulting 
from Pt(II)-Pt(II) and - interactions were hardly observed (Figures 5a and 5b) 
although 1:2 complexation of ND with U5Pt was verified by Job’s plots. The decrease 
in K values (logK1 = 2.95(2) and logK2 = 2.82(9)) between ND and U5Pt was 
observed.
3
 These results indicate the importance of the direction of the hydrogen 
bonding sites to arrange the [4-octyloxy-(C^N^N)Pt] moieties regularly. 
17 
 
 
 
Figure 4. (a) UV/vis spectra of ND, U6Pt, and ND-U6Pt (1:2) in dichloromethane 
([ND] = 0.5 x 10
3
 M, [U6Pt] = 1.0 x 10
3
 M) at 298 K, (b) emission spectra (ex = 530 
nm) of U6Pt and ND-U6Pt (1:2) in dichloromethane ([ND] = 0.5 x 10
3
 M, [U6Pt] = 
1.0 x 10
3
 M) at 298 K, 
 
 
 
Figure 5. UV/vis spectra of ND, U5Pt, and ND-U5Pt (1:2) in dichloromethane ([ND] = 
0.5 x 10
3
 M, [U5Pt] = 1.0 x 10
3
 M) at 298 K, (b) emission spectra (ex = 530 nm) of 
U5Pt and ND-U5Pt (1:2) in dichloromethane ([ND] = 0.5 x 10
3
 M, [U5Pt] = 1.0 x 
10
3
 M) at 298 K. 
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The Pt(II)-Pt(II) and - interactions in aggregated complexes is considered to 
be influenced by an interbase distance. The change of Pt(II)-Pt(II) and  interactions 
might be reflected on their absorption and emission properties. The molecular scaffold 
AD was also ascertained to form the 1:2 complex with U6Pt by Job’s plots, wherein the 
stepwise association constants (K1 and K2) were appraised to be logK1 = 5.05(4) and 
logK2 = 4.189(6), respectively.
3
 The appearance of a new shoulder band around 500 nm 
was caused by the addition of 0.5 molar equiv. amounts of AD composed of anthracene 
to a dichloromethane solution of U6Pt in the UV/vis spectrum. The new shoulder band 
is assignable to the MMLCT transition based on Pt(II)-Pt(II) and - interactions 
(Figure 6a). By the addition of 0.5 molar equiv. amounts of AD, the increase of the 
3
MMLCT emission at around 730 nm based on its synergistic effect and the decrease of 
the 
3
MLCT/
3
LLCT emission were also observed in the emission spectrum as shown in 
Figure 6b. 
 
 
Figure 6. UV/vis spectra of AD, U6Pt, and AD-U6Pt (1:2) in dichloromethane ([AD] = 
0.5 x 10
3
 M, [U6Pt] = 1.0 x 10
3
 M) at 298 K, (b) emission spectra (ex = 530 nm) of 
U6Pt and AD-U6Pt (1:2) in dichloromethane ([AD] = 0.5 x 10
3
 M, [U6Pt] = 1.0 x 
10
3
 M) at 298 K. 
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In comparison to the emission with the molecular scaffold ND composed of 
naphthalene, U6Pt aggregates with the AD exhibited the low intensity of the 
3
MMLCT 
emission and the high intensity of the 
3
MLCT emission probably because of the weak 
Pt(II)-Pt(II) and - interactions based on the longer interbase distance (Figure 7). The 
emission properties of U6Pt was revealed to be controlled by changing the molecular 
scaffold size.  
 
Figure 7. Schematic depiction of the controlled aggregation of the bioorganometallic 
platinum(II) compound U6Pt by using the molecular scaffolds of ND and AD. 
 
 
 
 
 
 
 
 
 
 
 
4.9 Å
AD : U6Pt = 1 : 2
2.5 Å
ND : U6Pt = 1 : 2
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1-3. Conclusion 
In conclusion, the designed organoplatinum(II)-uracil conjugate U6Pt was 
performed to form the dimeric structure through intermolecular hydrogen bonds 
between the uracil moieties of two independent molecules. The each hydrogen-bonded 
dimer was connected through Pt(II)-Pt(II) and  interactions in a packing structure. 
The tuning of the emission properties of the organoplatinum(II)-uracil conjugates was 
attained by changing the direction of hydrogen bonding sites and the molecular scaffold 
size. which affected the regulation of the aggregated structures, to induce the 
Pt(II)-Pt(II) and  interactions. The architectural control of molecular assemblies 
using preorganized molecular scaffolds is envisaged to be a useful approach to artificial 
highly-ordered systems without chemical synthesis.  
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1-4. Experimental section 
General methods 
 All reagents and solvents were purchased from commercial sources and were 
further purified by the standard methods, if necessary. All manipulations were 
performed under Ar. Melting points were measured with a Yanagimoto Micromelting 
Point Apparatus and were uncorrected. Infrared spectra were obtained with a JASCO 
FT/IR-480 Plus spectrometer. 
1
H NMR spectra were recorded on a JEOL JNM-ECS 400 
(400 MHz) spectrometer with tetramethylsilane as an internal standard. Mass spectra 
were run on a JEOL JMS DX-303 spectrometer. 
 6-Ethynyl-1-octyluracil,
4 
5-ethynyl-1-octyluracil,
5
 
4-benzyloxy-2,6-pyridinediamine,
6
 1,8-diiodonaphthalene
7
 and 
1,8-diethynylanthracene
8
 were prepared according to literature procedures. 
Synthesis of 6-(4-octyloxyphenyl)-2,2'-bipyridine (1) 
 A mixture of N-(2-pyridacyl)pyridinium iodide (3.4 g, 10 mmol), 
3-dimethylamino-1-(4-octyloxyphenyl)propan-1-one hydrochloride (3.3 g, 10 mmol), 
and NH4OAc (17 g, 0.22 mol) in glacial acetic acid (40 mL) was refluxed under Ar for 3 
days. After the addition of water and dichloromethane to the resulting mixture, the 
organic phase was washed with saturated NaHCO3 aqueous solution, and brine, and 
then dried over Na2SO4. The solvent was evaporated in vacuo and the residue was 
chromatographed on silica-gel column (eluent, CH2Cl2/EtOAc 49:1) to give the desired 
6-(4-octyloxyphenyl)-2,2'-bipyridine (1) (2.0 g, 5.5 mmol) as a white solid. 
 1: yield 55%; mp 61-62 °C; IR (KBr) 3279, 3048, 2917, 2850, 1607, 1582, 
1561, 1516, 1455, 1434, 1249, 1182, 1017 cm
1
; 
1
H NMR (400 MHz, CDCl3, 1.0 x 10
2
 
M)  8.69 (d, 1H, J = 4.0 Hz), 8.63 (d, 1H, J = 8.0 Hz), 8.31 (d, 1H, J = 8.0 Hz), 8.10 (d, 
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1H, J = 8.8 Hz), 7.90-7.80 (m, 2H), 7.71 (d, 1H, J = 8.0 Hz), 7.32 (dd, 1H, J = 8.0, 4.0 
Hz), 7.02 (d, 1H, J = 8.8 Hz ), 4.04 (t, 2H, J = 6.4 Hz), 1.86-1.79 (m, 2H), 1.52-1.45 (m, 
2H), 1.42-1.26 (m, 8H), 0.90 (t, 2H, J = 6.8 Hz); 
13
C NMR (100 MHz, CDCl
3
, 1.0 x 
10
2
 M) 160.1, 156.5, 156.2, 155.5, 149.0, 137.6, 136.9, 131.7, 128.2, 123.7, 121.3, 
119.5, 118.6, 114.7, 68.1, 31.8, 29.4, 29.3, 26.1, 22.7, 14.1 ppm; HRMS (FAB) m/z 
Calcd. for C24H29N2O (M
+
), 361.2274; Found, 361.2281; Anal. Calcd. for C24H28N2O: C, 
79.96; H, 7.83; N, 7.77. Found: C, 79.94; H, 7.82; N, 7.67. 
 
Synthesis of the platinum(II) complex 2 
 A mixture of 1 (100 mg, 0.28 mmol) and K2PtCl4 (165 mg, 0.40 mol) in a 
mixed solvent of acetonitrile (8.0 mL) and water (8.0 mL) was refluxed under Ar for 42 
h. After the reaction was completed, the acetonitrile was evaporated. The product was 
extracted with dichloromethane and the organic phase was washed with water, and brine, 
and then dried over Na2SO4. The solvent was evaporated in vacuo and the residue was 
washed with methanol to give the desired platinum(II) complex 2 (138 mg, 0.23 mmol) 
as an orange solid. 
 2: yield 84%; mp 153-154 °C (decomp.); IR (KBr) 3052, 2925, 2853, 1591, 
1544, 1435, 1263, 1203, 1034 cm
1
; 
1
H NMR (400 MHz, CDCl3, 1.0 x 10
2
 M)  8.99 
(d, 1H, J = 5.6, 1.6 Hz), 8.05 (dt, 1H, J = 8.0, 1.6 Hz), 7.90 (d, 1H, J = 8.0 Hz), 7.75 (t, 
1H, J = 8.0 Hz), 7.62 (dd, 1H, J = 8.0, 5.6 Hz), 7.47 (d, 1H, J = 8.0 Hz), 7.35 (d, 1H, J = 
8.0 Hz), 7.28 (d, 1H, J = 8.8 Hz), 7.13 (d, 1H, J = 2.8 Hz), 6.61 (dd, 1H, J = 8.8, 2.8 
Hz), 4.03 (t, 2H, J = 6.4 Hz), 1.82-1.75 (m, 2H), 1.52-1.44 (m, 2H), 1.41-1.26 (m, 8H), 
0.90 (t, 3H, J = 6.8 Hz); 
13
C NMR (100 MHz, CDCl3, 1.0 x 10
2
 M) 166.8, 161.6, 157.8, 
154.7, 149.3, 145.4, 139.8, 139.1, 138.7, 127.8, 126.5, 122.8, 119.7, 118.4, 117.0, 111.1, 
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68.3, 32.3, 29.8, 29.7, 26.5, 23.1, 14.3 ppm; HRMS (FAB) m/z Calcd. for 
C24H27ClN2OPt (M
+
), 589.1454; Found, 589.1456; Anal. Calcd. for 
C24H27ClN2OPt•0.5H2O: C, 48.12; H, 4.71; N, 4.68. Found: C, 48.29; H, 4.44; N, 4.58. 
 
Synthesis of the bioorganometallic platinum(II) complex U6Pt 
 To a dichloromethane (3.0 mL) solution of 6-ethynyl-1-octyluracil (50 mg, 
0.20 mmol), 2 (59 mg, 0.10 mmol), and CuI (1.5 mg, 7.9 mol) was added 
triethylamine (1.2 mL, 8.6 mmol) under Ar at room temperature in the dark. The 
resulting mixture was stirred at room temperature for 23 h and the solvent was 
evaporated. The residue was washed with methanol, and the bioorganometallic 
platinum(II) complex U6Pt was isolated as a dark red solid (76 mg, 95 mol) by 
recrystalization from dichloromethane and methanol.  
 U6Pt: yield 95%; mp 240-241 °C (decomp.); IR (KBr) 3427, 2925, 2853, 2089, 
1696, 1651, 1561, 1456, 1435, 1262, 1202, 1041 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 2.0 
x 10
3
 M)  8.97 (dd, 1H, J = 5.2, 1.6 Hz), 8.28 (br, 1H), 8.11 (td, 1H, J = 7.6, 1.6 Hz), 
7.95 (d, 1H, J = 7.6 Hz), 7.84 (t, 1H, J = 8.0 Hz), 7.63-7.57 (m, 2H), 7.52 (d, 1H, J = 
8.0 Hz), 7.37 (d, 1H, J = 8.4 Hz), 7.18 (d, 1H, J = 2.4 Hz), 6.62 (dd, 1H, J = 8.4, 2.4 
Hz), 5.83 (s, 1H), 4.22 (t, 2H, J = 7.6 Hz), 4.00 (t, 2H, J = 6.4 Hz), 1.87-1.75 (m, 4H), 
1.50-1.11 (m, 20H), 0.89 (t, 3H, J = 6.8 Hz), 0.77 (t, 3H, J = 6.8 Hz); 
13
C NMR (100 
MHz, CD2Cl2, 2.0 x 10
3
 M) 165.7, 163.2, 162.1, 158.6, 154.7, 152.1, 151.5, 143.6, 
142.7, 140.0, 139.9, 139.4, 128.2, 126.9, 124.2, 123.3, 118.7, 117.0, 110.5, 103.2, 97.2, 
68.3, 46.7, 32.3, 29.8, 29.7, 29.3, 27.3, 26.5, 23.1, 23.0, 14.3 ppm; HRMS (FAB) m/z 
Calcd. for C38H47N4O3Pt
194
 (M
+
), 801.3275; Found, 801.3268; Anal. Calcd. for 
C38H46N4O3Pt1•0.5H2O: C, 56.28; H, 5.84; N, 6.91. Found: C, 56.47; H, 5.53; N, 6.96. 
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Synthesis of the bioorganometallic platinum(II) complex U5Pt 
 To a dichloromethane (4.0 mL) solution of 5-ethynyl-1-octyluracil (75 mg, 
0.30 mmol), 2 (89 mg, 0.15 mmol), and CuI (1.8 mg, 9.5 mol) was added 
triethylamine (1.8 mL, 13 mmol) under Ar at room temperature in the dark. The 
resulting mixture was stirred at room temperature for 14 h and the solvent was 
evaporated. The product was extracted with dichloromethane. After evaporation of the 
solution, the bioorganometallic platinum(II) complex U5Pt was isolated as an orange 
solid (73 mg, 91 mol) by reprecipitation from dichloromethane and ether. 
 U5Pt: yield 61%; mp 197-199 °C (decomp.); IR (KBr) 3088, 3039, 2928, 2852, 
2106, 1695, 1659, 1581, 1547, 1435, 1351, 1225, 1173 cm
1
; 
1
H NMR (400 MHz, 
CD2Cl2, 2.5 x 10
3
 M)  9.36 (d, 1H, J = 5.2 Hz), 8.32 (s, 1H), 8.07 (t, 1H, J = 7.6 Hz), 
7.94 (d, 1H, J = 7.6 Hz), 7.80 (t, 1H, J = 8.0 Hz), 7.63 (dd, 1H, J = 7.6, 5.2 Hz), 7.58 (d, 
1H, J = 8.0 Hz), 7.48 (d, 1H, J = 8.0 Hz), 7.44 (s, 1H), 7.39 (d, 1H, J = 2.4 Hz), 7.37 (d, 
1H, J = 8.4 Hz), 6.60 (dd, 1H, J = 8.4, 2.4 Hz), 4.07 (t, 2H, J = 6.4 Hz), 3.72 (t, 2H, J = 
7.2 Hz), 1.83-1.68 (m, 4H), 1.52-1.25 (m, 20H), 0.91-0.87 (m, 6H); 
13
C NMR (100 
MHz, CD2Cl2, 2.5 x 10
3
 M) 165.7, 163.4, 162.1, 158.7, 154.9, 152.5, 150.2, 144.8, 
143.7, 139.6, 139.4, 139.3, 128.2, 126.6, 124.0, 122.9, 118.4, 116.9, 112.6, 110.3, 104.8, 
94.7, 68.3, 49.1, 32.3, 32.2, 29.9, 29.8, 29.7, 29.6, 29.5, 26.9, 26.5, 23.1, 23.0, 14.3, 
14.2 ppm; HRMS (FAB) m/z Calcd. for C38H47N4O3Pt
194
 (M
+
), 801.3275; Found, 
801.3267; Anal. Calcd. for C38H46N4O3Pt1•0.5H2O: C, 56.28; H, 5.84; N, 6.91. Found: 
C, 56.49; H, 5.55; N, 6.98. 
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Synthesis of 2,6-dihexamido-4-ethynylpyridine (7) 
 2,6-Dihexamido-4-ethynylpyridine (7) was synthesized from 
4-benzyloxy-2,6-pyridinediamine in 5 steps. To a dichloromethane (100 mL) solution of 
4-benzyloxy-2,6-pyridinediamine (2.2 g, 10 mmol) and triethylamine (5.6 mL, 40 
mmol) was added a dichloromethane (50 mL) solution of heptanoylchloride (3.3 mL, 21 
mmol) dropwise under Ar at 0 °C. The resulting mixture was stirred at room 
temperature for 12 h. The resulting mixture was diluted with dichloromethane, washed 
with saturated NaHCO3 aqueous solution and brine, and then dried over Na2SO4. The 
solvent was evaporated in vacuo and the residue was chromatographed on silica-gel 
column (eluent, CH2Cl2) to give 3 (3.3 g, 7.6 mmol).  
 3: yield 76%; mp 54-56 °C; IR (KBr) 3424, 3325, 2953, 2926, 2860, 2367, 
1692, 1673, 1583, 1541, 1503, 1440 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 5.0 x 10
2
 M)  
7.66 (s, 2H), 7.61 (s, 2H), 7.46-7.32 (m, 5H), 5.14 (s, 2H), 2.33 (t, J = 7.5 Hz, 4H), 
1.70-1.63 (m, 4H), 1.38-1.28 (m, 12H), 0.89 (t, J = 7.0 Hz, 6H); 
13
C NMR (100 MHz, 
CD2Cl2, 5.0 x 10
2
 M) 172.0, 168.8, 151.3, 136.5, 128.9, 128.5, 128.1, 96.2, 70.5, 38.1, 
31.9, 29.2, 25.6, 22.9, 14.2 ppm; HRMS (FAB) m/z Calcd. for C26H38N3O3 (M
+
), 
440.2908; Found, 440.2924. 
 Benzyl ether 3 (5.6 g, 13 mmol) was dissolved in a mixture of ethanol (60 mL). 
Pd/C (10 weight%, 0.59 g) was added and the reaction mixture was placed under H2, 
stirred at room temperature for 18 h and filtered through celite. The solvent was 
evaporated in vacuo and the residue was chromatographed on silica-gel column (eluent, 
EtOAc) to give 4 (4.0 g, 12 mmol).  
 4: yield 90%; mp 80-82 °C; IR (KBr) 3271, 2956, 2929, 2858, 1657, 1597, 
1464, 1435, 1230 cm
1
; 
1
H NMR (400 MHz, CDCl
3
, 1.0 x 10
2
 M)  10.03 (s, 1H), 7.67 
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(s, 2H), 7.55 (s, 2H), 2.38 (t, J = 7.6 Hz, 4H), 1.75-1.68 (m, 4H), 1.41-1.25 (m, 12H), 
0.89 (t, J = 6.4 Hz, 6H); 
13
C NMR (100 MHz, CDCl3, 1.0 x 10
2
 M) 172.6, 168.0, 150.1, 
98.0, 38.1, 31.5, 28.8, 25.4, 22.5, 14.0 ppm; HRMS (FAB) m/z Calcd. for C19H32N3O3 
(M
+
), 350.2438; Found,350.2454; Anal. Calcd. for C19H31N3O3: C, 65.30; H, 8.94; N, 
12.02. Found: C, 65.05; H, 8.94; N, 11.84. 
 To a pyridine (6.5 mL, 80 mmol) solution of 4 (700 mg, 2.0 mmol) was added 
trifluoromethanesulfonic anhydride (0.5 mL, 3.0 mmol) dropwise under Ar at 0 °C. The 
reaction mixture was stirred at room temperature for 3 h. After removal of the solvent, 
the residue was poured into water and extracted with diethyl ether. The diethyl ether 
extract was evaporated in vacuo and the residue was chromatographed on silica-gel 
column (eluent, hexane/EtOAc 4:1) to give 5 (810 mg, 1.7 mmol). 
 5: yield 84%; mp 49-51 °C; IR (KBr) 3396, 3261, 3120, 3040, 2958, 2931, 
2862, 2362, 1686, 1605, 1523, 1433, 1212 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 5.0 x 
10
2
 M)  7.93 (s, 2H), 7.80 (s, 2H), 2.38 (t, J = 7.7 Hz, 4H), 1.73-1.64 (m, 4H), 
1.40-1.29 (m, 12H), 0.89 (t, J = 7.0 Hz, 6H); 
13
C NMR (100 MHz, CD2Cl2, 5.0 x 10
2
 
M) 172.2, 159.0, 151.8, 119.0, 101.9, 38.0, 31.9, 29.2, 25.4, 22.9, 14.2 ppm; HRMS 
(FAB) m/z Calcd. for C20H31F3N3O5S1 (M
+
), 482.1931; Found, 482.1949 
 To a triethylamine (24 mL) solution of 5 (1.9 g, 4.0 mmol), PdCl2(Ph3P)2 (0.14 
g, 0.20 mmol), and CuI (19 mg, 0.10 mmol) was added (trimethylsilyl)acetylene (2.8 
mL, 20 mmol) under Ar at room temperature. The reaction mixture was stirred at 50 °C 
for 14 h. After removal of the solvent, the residue was poured into water and extracted 
with dichloromethane. The dichloromethane extract was evaporated in vacuo and the 
residue was chromatographed on silica-gel column (eluent, CH2Cl2) to give 6 (1.7 g, 3.9 
mmol). 
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 6: yield 98%; IR (KBr) 3282, 2958, 2947, 2858, 2168, 1675, 1609, 1557, 1419, 
1211 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 5.0 x 10
2
 M)  7.93 (s, 2H), 7.86 (s, 2H), 2.34 
(t, J = 7.6 Hz, 4H), 1.70-1.62 (m, 4H), 1.36-1.27 (m, 12H), 0.88 (t, J = 7.0 Hz, 6H), 0.24 
(s, 9H); 
13
C NMR (100 MHz, CD2Cl2, 5.0 x 10
2
 M) 172.0, 150.3, 135.6, 111.6, 102.8, 
99.7, 38.0, 31.9, 29.2, 25.6, 22.9, 14.2, -0.3 ppm; HRMS (FAB) m/z Calcd. for 
C24H40N3O2Si1 (M
+
), 430.2884; Found, 430.2899. 
 A mixture of 6 (1.6 g, 3.7 mmol) and KOH (0.41 g, 7.3 mmol) in methanol (55 
mL) was stirred at room temperature under Ar for 4 h. The resulting mixture was diluted 
with ethyl acetate, washed with water and brine, and then dried over Na2SO4. The ethyl 
acetate extract was evaporated in vacuo and the residue was chromatographed on 
silica-gel column (eluent, CH2Cl2/EtOAc 9:1) to give 7 (0.98 g, 2.7 mmol). 
 7: yield 73%; mp 45-47 °C; IR (KBr) 3566, 3402, 3278, 2955, 2927, 2857, 
2116, 1672, 1613, 1557, 1507, 1419, 1212 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 5.0 x 
10
2
 M)  7.97 (s, 2H), 7.67 (s, 2H), 3.31 (s, 1H), 2.35 (t, J = 7.6 Hz, 4H), 1.72-1.64 (m, 
4H), 1.38-1.29 (m, 12H), 0.89 (t, J = 7.0 Hz, 6H); 
13
C NMR (100 MHz, CD2Cl2, 5.0 x 
10
2
 M) 171.9, 150.4, 134.7, 111.9, 81.8, 81.5, 38.1, 31.9, 29.2, 25.6, 22.9, 14.2 ppm; 
HRMS (FAB) m/z Calcd. for C21H32N3O2 (M
+
), 358.2489; Found, 358.2499; Anal. 
Calcd. for C21H31N3O2•0.5H2O: C, 68.82; H, 8.80; N, 11.47. Found: C, 68.78; H, 8.76; 
N, 11.19. 
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Synthesis of the molecular scaffold ND 
 To a DMF (7.5 mL) solution of 1,8-diiodonaphthalene (92 mg, 0.24 mmol), 7 
(0.26 g, 0.72 mmol), PdCl2(Ph3P)2 (15 mg, 20 mol), and CuI (4.8 mg, 25 mol) was 
added triethylamine (2.5 mL, 18 mmol) at room temperature. The resulting mixture was 
stirred under Ar at 55 °C for 21 h. The resulting mixture was diluted with 
dichloromethane, washed with water and brine, and then dried over Na2SO4. The 
solvent was evaporated in vacuo and the residue was chromatographed on silica-gel 
column (eluent, CHCl3/EtOAc 19:1) to give ND (79 mg, 95 mol) as a white solid. 
 ND: yield 40%; mp 178-180 °C; IR (KBr) 3296, 3050, 2954, 2928, 2856, 2211, 
1703, 1672, 1610, 1555, 1420, 1260, 1213, 1168 cm
1
; 
1
H NMR (400 MHz, CDCl3, 5.0 
x 10
3
 M)  7.95-7.91 (m, 4H), 7.77 (s, 4H), 7.55-7.52 (m, 6H), 2.30 (t, 8H, J = 7.7 Hz, 
H), 1.65(q, J = 7.7 Hz, 8H), 1.39-1.28 (m, 24H), 0.90 (t, J = 7.0 Hz, 12H); 
13
C NMR 
(100 MHz, CDCl3, 5.0 x 10
3
 M) 171.3, 149.8, 136.1, 135.9, 134.4, 131.7, 130.9, 126.2, 
120.0, 111.5, 95.1, 93.9, 37.9, 32.0, 29.3, 25.6, 22.9, 14.2 ppm; HRMS (FAB) m/z Calcd. 
for C53H67N6O4 (M
+
), 839.5218; Found, 839.5220; Anal. Calcd. for C52H66N6O4•H2O: C, 
72.87; H, 8.00; N, 9.80. Found: C, 73.14; H, 7.78; N, 9.69. 
 
Synthesis of the molecular scaffold AD 
 To a tetrahydrofuran (3.5 mL) solution of 1,8-diethynylanthracene (91 mg, 0.40 
mmol), 5 (0.48 g, 1.0 mmol), PdCl2(Ph3P)2 (8.4 mg, 12 mol), and CuI (2.3 mg, 12 
mol) was added triethylamine (1.5 mL, 11 mmol) at room temperature. The resulting 
mixture was stirred under Ar at 50 °C for 17 h. The resulting mixture was diluted with 
dichloromethane, washed with water and brine, and then dried over Na2SO4. The 
solvent was evaporated in vacuo and the residue was chromatographed on silica-gel 
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column (eluent, CH2Cl2/MeOH 19:1) to give AD (98 mg, 0.11 mmol) as a pale yellow 
solid. 
 AD: yield 28%; mp 213-215 °C; IR (KBr) 3057, 2955, 2927, 2856, 2208, 1708, 
1609, 1556, 1501, 1418, 1264, 1212, 1166 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 5.0 x 
10
3
 M)  9.56 (s, 1H), 8.56 (s, 1H), 8.12 (d, J = 8.8 Hz, 2H), 7.98 (s, 4H), 7.88 (d, J = 
6.8 Hz, 2H), 7.55 (dd, J = 8.8, 6.8 Hz, 2H), 2.27 (t, J = 7.6 Hz, 8H), 1.65-1.56 (m, 8H), 
1.37-1.26 (m, 24H), 0.91 (t, J = 6.8 Hz, 12H); 
13
C NMR (100 MHz, CD2Cl2, 5.0 x 10
3
 
M) 171.4, 150.1, 135.8, 132.0, 131.9, 131.8, 130.3, 128.2, 125.7, 124.3, 120.9, 111.6, 
93.7, 91.9, 37.9, 32.0, 29.4, 25.5, 23.0, 14.2 ppm; HRMS (FAB) m/z Calcd. for 
C56H69N6O4 (M
+
), 889.5375; Found, 889.5370. 
 
Physical measurements 
 UV/vis spectra were obtained using a Hitachi U-3500 spectrophotometer in a 
deaerated dichloromethane solution under nitrogen at 298 K. Emission spectra were 
collected using a Shimadzu RF-5300PC spectrofluorophotometer in a deaerated 
dichloromethane solution under nitrogen at 298 K.  
 
1
H NMR titrations 
 The CD2Cl2 solution of ND or AD with a concentration 0.5 x 10
3
 M 
containing various amounts of U6Pt or U5Pt was prepared and 
1
H NMR spectra were 
measured at 295 K. The changes in chemical shift of ND or AD signals as a function of 
U6Pt or U5Pt were then analyzed. Titration data for three different signals were used to 
determine the association constant in each experiment.  
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Job’s plots 
 For each component of the complex, 5.0 mL CD2Cl2 solutions of accurately 
measured and identical concentrations (2.0 x 10
3
 M) were prepared. The two solutions 
were then combined to give a series of samples of identical total concentration (2.0 x 
10
3
 M) containing different mole fractions of the two components. The 
1
H NMR 
spectrum of each sample was then measured at 295 K, and these spectra were used to 
produce a graph of  x [H] against [H]/([H] + [G]) shown as the Job’s plots. 
 
 
Figure 8. (a) Job’s plots for complexation of ND with U6Pt, where  x [ND] was 
plotted against [ND]/([ND] + [U6Pt]) at an invariant total concentration of 2.0 x 10
3
 M 
in CD2Cl2 at 295 K, (b) Job’s plots for complexation of AD with U6Pt, where  x 
[AD] was plotted against [AD]/([AD] + [U6Pt]) at an invariant total concentration of 
2.0 x 10
3
 M in CD2Cl2 at 295 K and (c) Job’s plots for complexation of ND with U5Pt, 
where  x [ND] was plotted against [ND]/([ND] + [U5Pt]) at an invariant total 
concentration of 2.0 x 10
3
 M in CD2Cl2 at 295 K. 
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X-ray structure analysis 
 All measurements for U6Pt were made on a Rigaku R-AXIS RAPID 
diffractometer using graphite monochromated Mo K radiation. The structure of U6Pt 
was solved by direct methods
9
 and expanded using Fourier techniques. All calculations 
were performed using the CrystalStructure crystallographic software package
10
 except 
for the refinement, which was performed using SHELXL-97.
11
 The non-hydrogen atoms 
were refined anisotropically. The H atoms involved in hydrogen bonding were located 
in electron density maps. The remainder of the H atoms were placed in idealized 
positions and allowed to ride with the C atoms to which each was bonded. 
Crystallographic details are given in Table 2. Selected bond distances and angles of 
U6Pt are reported in Table 3. Crystallographic data (excluding structure factors) for the 
structures reported in this paper have been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication no. CCDC-851423 for U6Pt. 
Copies of the data can be obtained free of charge on application to CCDC, 12 Union 
Road, Cambridge CB2 1EZ, UK [Fax: (internat.) +44-1223/336-033; E-mail: 
deposit@ccdc.cam.ac.uk]. 
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Table 2. Crystallographic data for U6Pt 
  U6Pt 
  Formula C38.5H47N4O3Pt1Cl1 
Molecular weight 844.36 
Crystal system Triclinic 
Space group P-1 (No. 2) 
a (Å) 12.1080(4) 
b (Å) 14.5494(5) 
c (Å) 20.4353(7) 
 (°) 89.7533(9) 
 (°) 88.4541(9) 
(°) 83.7668(9) 
V (Å
3
) 3577.4(2) 
Z 4 
Dcalcd (g cm
-3
) 1.568 
 (Mo Ka) (cm
-1
) 40.236 
T (°C) 150 
 (Mo K) (Å) 0.71075 
R1
a
 0.065 
wR2
b
 0.214 
  (a) R1 = ||Fo| |Fc|| / |Fo|. 
 
(b) wR2 = [w(Fo
2 
Fc
2
)
2 
/ w(Fo
2
)
2
]
1/2
. 
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Table 3. Selected bond distances (Å) and angles (°) for U6Pt 
            U6Pt 
   Bond distances (Å) 
  
Pt(1)N(1) 2.112(9) 2.141(9) 
Pt(1)N(2) 1.983(8) 1.985(8) 
Pt(1)C(16) 2.010(11) 2.010(9) 
Pt(1)C(25) 1.949(9) 1.931(9) 
O(2)C(28) 1.234(12) 1.225(12) 
O(3)C(29) 1.234(12) 1.259(12) 
N(3)C(27) 1.390(13) 1.394(13) 
N(3)C(28) 1.399(12) 1.397(12) 
N(4)C(28) 1.358(13) 1.373(13) 
N(4)C(29) 1.389(12) 1.371(13) 
C(25)C(26) 1.211(13) 1.220(13) 
C(26)C(27) 1.437(13) 1.419(13) 
C(27)C(30) 1.340(14) 1.344(14) 
C(29)C(30) 1.433(12) 1.409(13) 
   
Bond angles (°) 
  
N(1)Pt(1)N(2) 77.8(4) 79.1(4) 
N(1)Pt(1)C(16) 160.3(4) 160.7(4) 
N(1)Pt(1)C(25) 101.2(4) 99.8(4) 
N(2)Pt(1)C(16) 82.5(4) 81.7(4) 
N(2)Pt(1)C(25) 176.3(4) 178.8(4) 
C(16)Pt(1)C(25) 98.4(4) 99.5(4) 
N(3)C(28)N(4) 116.3(9) 114,7(8) 
N(4)C(29)C(30) 114.7(8) 114.8(9) 
C(27)N(3)C(28) 121.0(8) 122.1(8) 
C(27)N(3)C(29) 125.9(8) 126.7(8) 
   (a) Two independent molecules exist in an asymmetric unit. 
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Chapter 2. Synthesis and structural properties of mononuclear 
organogold(I) complexes bearing uracil moieties 
2-1. Introduction 
Organogold(I) complex has drawn increasing attention because of their 
aggregation properties through an attractive aurophilic interaction.
1
 This aurophilic 
interaction possesses the comparable strength to a hydrogen bonding and is useful for 
construction of supramolecular architectures in a solid state. A combination of 
organogold(I) complexes with nucleobases is envisaged to provide highly-organized 
assembly bioorganometallic systems depending on both properties. Herein I report the 
structural characterization of organogold(I)-uracil conjugates to disclose the steric 
effects of ancillary ligands on assembly properties of the uracil and the gold(I) moieties 
in a solid state. 
 
2-2. Results and discussion 
The organogold(I)-uracil conjugates were designed by introduction of planar 
phenyl isocyanide and bulky triphenylphosphine as an ancillary ligand to clarify the 
effect of ancillary ligands on the assembly properties. The synthesis of 
organogold(I)-uracil conjugates U6AuCNPh and U6AuPPh3 is depicted in Scheme 1. 
The organogold(I)-uracil conjugate bearing planar phenyl isocyanide U6AuCNPh was 
obtained by the coupling reaction of 6-ethynyl-1-octyluracil with chloro(phenyl 
isocyanide)gold(I) [(PhNC)AuCl], which was prepared by the treatment of 
chloro(tetrahydrothiophene)gold(I) [(tht)AuCl] with phenyl isocyanide, in the presence 
of CuI as a catalyst. The reaction of 6-ethynyl-1-octyluracil with 
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chloro(triphenylphosphine)gold(I), which was prepared by the treatment of 
chloro(tetrahydrothiophene)gold(I) with triphenylphosphine in situ, in the presence of 
sodium bis(trimethylsilyl)amide produced the organogold(I)-uracil conjugate bearing  
bulky triphenylphosphine U6AuPPh3. The formation of thus-obtained 
organogold(I)-uracil conjugates was confirmed by 
1
H NMR, 
13
C NMR, 
31
P NMR, IR, 
HRMS, and elemental analysis. For example, the uracil proton showed upfield shift in 
the 
1
H NMR spectra after the introduction of the gold(I) center. 
 
 
Scheme 1. 
 
The structural features of U6AuCNPh and U6AuPPh3 were confirmed by 
single-crystal X-ray structure determination, revealing the self-assembly properties of 
the gold(I) and uracil moieties. The crystal structure of U6AuCNPh possess propeller 
twist conformation with a dihedral angle of 45.9(4)° between the planes of the uracil 
and benzene moieties of phenyl isocyanide (Figure 1a). It is noteworthy that a 
head-to-tail dimer through the Au(I)-Au(I) and  interactions between the uracil and 
benzene moieties of phenyl isocyanide was formed in a crystal packing as shown in 
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Figure 1b. Furthermore, each head-to-tail dimer was linked with not only the 
intermolecular hydrogen bonds of N-H•••O pattern between the uracil moieties but the 
weak hydrogen bonds of C-H•••O pattern between the uracil and benzene moieties of 
phenyl isocyanide (Figure 1c and Table 1). 
 
 
Figure 1. (a) Molecular structure, (b) a head-to-tail dimer, and (c) a part of the 
intermolecular hydrogen bonds of N-H•••O pattern between the uracil moieties and the 
weak hydrogen bonds of C-H•••O pattern between the uracil and benzene moieties of 
phenyl isocyanide of U6AuCNPh (octyl moieties are omitted for clarity). 
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Table 1. Intermolecular hydrogen bonds for U6AuCNPh and U6AuPPh3
a
 
Compounds Donor Acceptor D•••A (Å) DH•••A (°) 
     U6AuCNPh N(2) O(2)
b
 2.827(12) 160(11) 
 
C(19) O(1)
c
 3.159(14) 125.2(8) 
 
C(20) O(1)
c
 3.210(13) 119.0(8) 
 
C(20) O(2)
d
 3.468(15) 146.2(2) 
     
U6AuPPh3 N(2) O(52)
e
 2.854(9) 168(5) 
 
N(52) O(2)
e
 2.849(8) 168(3) 
     (a) Two independent molecules exist in an asymmetric unit. (b) X, Y, Z1. 
(c) X, Y+1/2, Z. (d) X, Y+1/2, Z+1. (e) X+1/2, Y+1/2, Z+1. 
 
The organogold(I)-uracil conjugate U6AuPPh3 crystallized in the space group 
C2/c (Z = 16) and two independent molecules of U6AuPPh3 exist in an asymmetric unit. 
The structural characterization of U6AuPPh3 is confirmed by the formation of the 
dimeric structure through intermolecular hydrogen bonds of N-H•••O pattern between 
the uracil moieties of two independent molecules as shown in Figure 2. Self-assembly 
properties of the organogold(I)-uracil conjugates were found to depend on the ancillary 
ligands. In comparison with the self-assembly properties of U6AuCNPh, the crystal 
structure of U6AuPPh3 showed no Au(I)-Au(I) interaction probably due to the sterically 
bulky triphenylphosphine ligand (Figure 2b). 
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Figure 2. (a) Molecular structure and (b) a hydrogen-bonded dimer through 
intermolecular hydrogen bonds between the uracil moieties of U6AuPPh3. 
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2-3. Conclusions 
The bioorganometallic compounds consisted of the organogold(I) complexes 
with uracil moiety as a nucleobase were designed and synthesized. The structural 
characterization of organogold(I)-uracil conjugates was demonstrated to disclose the 
assembly properties of the gold(I) and the uracil moieties in a solid state. Interesting 
feature of organogold(I)-uracil conjugates is their strong tendency to self-assemble 
through intermolecular hydrogen bonds, wherein hydrogen bonding patterns were found 
to depend on the ancillary ligands. Furthermore, the introduction of planar phenyl 
isocyanide as an ancillary ligand induced the formation of a head-to-tail dimer through 
the Au(I)-Au(I) and  interactions between the uracil and the benzene moieties of 
phenyl isocyanide. On the contrary, the Au(I)-Au(I) interaction was not observed in the 
case of bulky triphenylphosphine ancillary ligand probably due to the steric hindrance.  
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2-4. Experimental section 
General methods 
 All reagents and solvents were purchased from commercial sources and were 
further purified by the standard methods, if necessary. 6-ethynyl-1-octyluracil,
2
 
chloro(tetrahydrothiophene)gold(I) [(tht)AuCl]
3
 and chloro(phenyl isocyanide)gold(I) 
[(PhNC)AuCl]
4
 were prepared by the literature methods. Infrared spectra were obtained 
with a JASCO FT/IR-6200 spectrometer. 
1
H, 
13
C, and 
31
P NMR spectra were recorded 
on a JNM-ECS 400 (400, 100, and 160 MHz, respectively) spectrometer. For 
1
H and 
31
P 
NMR spectra, chemical shifts were determined by using of tetramethylsilane and 85% 
H3PO4 aq. as standard samples, respectively. Chemical shifts of 
13
C NMR spectra were 
determined relative to the solvent residual peaks. Mass spectra were run on a JEOL 
JMS-700 mass spectrometer. 
 
Synthesis of (1-octyluracil-6-)ethynyl(phenyl isocyanide)gold(I) U6AuCNPh  
 To a mixture of chloro(phenyl isocyanide)gold(I) (67 mg, 0.20 mmol), 
6-ethynyl-1-octyluracil (50 mg, 0.20 mmol), CuI (1.9 mg, 10 mol), and NaOAc (33 
mg, 0.40 mmol) were added dichloromethane (16 mL) and methanol (4.0 mL). The 
resulting mixture was stirred at room temperature for 9 h under Ar in the dark. The 
solvent was evaporated and the residue was extracted with dichloromethane, insoluble 
impurities was filtered out. The solvent was evaporated and purification of the crude 
product by recrystallization from dichloromethane, diethyl ether, and hexane gave the 
desired gold(I) complex U6AuCNPh (53 mg, 0.096 mmol) as a pale yellow crystal.  
 U6AuCNPh: yield 48%; IR (KBr) 3150, 2924, 2855, 2228, 2124, 1712, 1656, 
1574, 1465, 1416, 1364 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 4.0 x 10
2
 M):  8.97 (br, 
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1H), 7.64-7.52 (m, 5H), 5.73 (s, 1H), 4.03 (t, 1H, J = 7.6 Hz), 1.38-1.29 (m, 10H), 
1.50-1.11 (m, 20H), 0.89 (t, 3H, J = 6.8 Hz); 
13
C NMR (100 MHz, CD2Cl2, 4.0 x 10
2
 
M): 163.4, 155.0 (t, J = 24.9 Hz), 151.4, 140.2, 140.0, 132.3, 130.5, 127.4, 124.6 (t, J = 
14.4 Hz), 105.7, 93.7, 46.7, 32.4, 29.7, 29.6, 28.9, 27, 23.2, 14.4 ppm; HRMS (FAB) 
m/z Calcd. for C21H25N3O2Au (M + H
+
), 548.1607; found, 548.1612; Anal. Calcd. for 
C21H24N3O2Au: C, 46.08; H, 4.42; N, 7.68. Found: C, 45.78; H, 4.37; N, 7.68. 
 
Synthesis of (1-octyluracil-6-)ethynyl(triphenylphosphine)gold(I) U6AuPPh3 
 A mixture of triphenylphosphine (53 mg, 0.20 mmol), 
chloro(tetrahydrothiophene)gold(I) (64 mg, 0.20 mmol), and 6-ethynyl-1-octyluracil (50 
mg, 0.20 mmol) was stirred in THF (10 mL) at room temperature for 15 minutes under 
Ar. To the solution was added sodium bis(trimethylsilyl)amide (40 mg, 0.22 mmol) and 
the resulting solution was stirred at room temperature under Ar for 21 h. The mixture 
was diluted with dichloromethane, washed with water, brine, and then dried over 
Na2SO4. The solvent was evaporated and purification of the crude product by 
recrystallization from dichloromethane, diethyl ether, and hexane gave the desired 
gold(I) complex U6AuPPh3 (68 mg, 0.096 mmol) as a colorless crystal. 
 U6AuPPh3: yield 48%; IR (KBr) 3170, 3074, 2923, 2852, 2116, 1698, 1661, 
1574, 1456, 1402, 1366 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 1.0 x 10
2
 M):  8.30 (br, 
1H), 7.59-7.48 (m, 15H), 5.74 (s, 1H), 4.06 (t, 2H, J = 7.6 Hz), 1.77-1.69 (m, 2H), 
1.41-1.21 (m, 10H), 0.80 (t, 3H, J = 6.8 Hz); 
13
C NMR (100 MHz, CD2Cl2, 1.0 x 10
2
 
M): 163, 151.4 (d, 
2
JC-P = 142.3 Hz), 151.2, 140.3 (d, 
4
JC-P = 3.1 Hz), 134.6 (d, 
2
JC-P = 
13.7 Hz), 132.2 (d, 
4
JC-P = 2.2 Hz), 129.6 (d, 
3
JC-P = 11.3 Hz), 129.6 (d, 
1
JC-P = 57 Hz), 
105.2, 93.8 (d, 
3
JC-P = 26.6 Hz), 46.7, 32.2, 29.6, 29.5, 28.9, 27, 23, 14.2 ppm; 
31
P NMR 
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(160 MHz, CD2Cl2, 1.0 x 10
2
 M): 41.8 ppm; HRMS (FAB) m/z Calcd for 
C32H35N2O2PAu (M + H
+
), 707.2096; Found, 707.2096; Anal. Calcd. for 
C32H34N2O2PAu: C, 54.40; H, 4.85; N, 3.96. Found: C, 54.37; H, 4.95; N, 4.02. 
 
X-ray structure analysis 
 All measurements for U6AuCNPh were performed with a Rigaku R-AXIS 
RAPID diffractometer by using graphite-monochromated Mo-Kα radiation. All 
measurements for U6AuPPh3 were performed with a Rigaku R-AXIS RAPID 
diffractometer by using filtered Mo-K radiation. The structures of U6AuCNPh and 
U6AuPPh3 were solved by direct methods
5
 and expanded using Fourier techniques. All 
calculations were performed using the CrystalStructure crystallographic software 
package
6
 except for the refinement, which was performed using SHELXL-97.
7 
The 
non-hydrogen atoms were refined anisotropically. The H atoms involved in hydrogen 
bonding were located in electron density maps. The remainder of the H atoms were 
placed in idealized positions and allowed to ride with the C atoms to which each was 
bonded. Crystallographic details are given in Table 2. Selected bond distances and 
angles are shown in Table 3 and 4. Crystallographic data (excluding structure factors) 
for the structures reported in this paper have been deposited with the Cambridge 
Crystallographic Data Centre as supplementary publication no. CCDC-1026761 for 
U6AuCNPh and CCDC-1026762 for U6AuPPh3. Copies of the data can be obtained 
free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [Fax: 
(internat.) +44-1223/336-033; E-mail: deposit@ccdc.cam.ac.uk]. 
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Table 2. Crystallographic data for U6AuCNPh and U6AuPPh3 
  U6AuCNPh U6AuPPh3 
   Formula C21H24N3O2Au1 C32H34N2O2P1Au1 
Molecular weight 541.41 706.57 
Crystal system Tetragonal Monoclinic 
Space group I41/a (No. 88) C2/c (No. 15) 
a (Å) 35.091(3) 38.4526(14) 
b (Å) 
 
16.5099(4) 
c (Å) 6.7679(6) 20.2551(7) 
 (°) 
 
114.7260(11) 
V (Å
3
) 8334.0(12) 11680.0(7) 
Z 16 16 
Dcalcd (g cm
-3
) 1.745 1.607 
 (Mo Ka) (cm
-1
) 71.052 51.414 
T (°C) 150 170 
 (Mo K) (Å) 0.71075 0.71075 
R1
a
 0.062 0.060  
wR2
b
 0.156 0.152 
   (a) R1 = ||Fo| |Fc|| / |Fo|. (b) wR2 = [w(Fo
2 
Fc
2
)
2 
/ w(Fo
2
)
2
]
1/2
. 
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Table 3. Selected bond distances (Å) for U6AuCNPh and U6AuPPh3  
 
U6AuCNPh          U6AuPPh3
a
 
    Au(1)C(15) 1.982(11) 
  
Au(1)P(1) 
 
2.2783(18) 2.2762(18) 
Au(1)C(14) 1.990(11) 1.998(8) 2.002(8) 
P(1)C(15) 
 
1.818(10) 1.821(10) 
P(1)C(21) 
 
1.811(8) 1.825(7) 
P(1)C(27) 
 
1.812(7) 1.806(7) 
O(1)C(1) 1.242(14) 1.220(9) 1.22613) 
O(2)C(2) 1.215(15) 1.230(8) 1.223(10) 
N(1)C(1) 1.361(14) 1.392(10) 1.364(13) 
N(1)C(4) 1.415(14) 1.391(10) 1.356(12) 
N(2)C(1) 1.356(16) 1.381(9) 1.333(12) 
N(2)C(2) 1.420(15) 1.393(9) 1.360(10) 
N(3)C(15) 1.134(14) 
  
N(3)C(16) 1.404(13) 
  
C(2)C(3) 1.425(15) 1.427(10) 1.433(11) 
C(3)C(4) 1.350(16) 1.364(10) 1.356(11) 
C(4)C(13) 1.421(14) 1.436(11) 1.410(10) 
C(13)C(14) 1.198(14) 1.205(12) 1.214(11) 
    (a) Two independent molecules exist in an asymmetric unit. 
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Table 4. Selected bond angles (°) for U6AuCNPh and U6AuPPh3  
 
U6AuCNPh         U6AuPPh3
a
 
    C(14)Au(1)C(15) 176.0(4) 
  
P(1)Au(1)C(14) 
 
176.3(3) 176.2(2) 
Au(1)C(15)N(3) 176.4(9) 
  
Au(1)P(1)C(15) 
 
111.5(2) 111.5(3) 
Au(1)P(1)C(21) 
 
116.2(3) 116.6(3) 
Au(1)P(1)C(27) 
 
110.8(2) 112.4(2) 
Au(1)C(14)C(13) 173.6(9) 177.6(8) 174.4(9) 
O(1)C(1)N(1) 123.1(11) 122.9(7) 121.8(9) 
O(1)C(1)N(2) 120.7(10) 122.3(7) 121.5(9) 
O(2)C(2)N(2) 120.2(10) 119.5(6) 119.3(7) 
O(2)C(2)C(3) 126.0(11) 125.9(7) 125.6(8) 
N(1)C(1)N(2) 116.1(10) 114.8(6) 116.7(9) 
N(1)C(4)C(3) 119.9(9) 121.2(7) 118.5(7) 
N(1)C(4)C(13) 117.9(9) 116.3(6) 119.4(7) 
N(2)C(2)N(3) 113.8(10) 125.9(7) 115.1(7) 
C(1)N(1)C(4) 122.0(9) 121.6(6) 123.0(9) 
C(1)N(2)C(2) 126.4(9) 126.7(6) 125.5(7) 
C(2)C(3)C(4) 121.5(10) 121.0(7) 120.7(7) 
C(3)C(4)C(13) 122.2(10) 122.5(7) 121.9(7) 
C(4)C(13)C(14) 172.7(11) 178.1(12) 174.7(11) 
C(15)N(3)C(16) 176.4(11) 
  
    (a) Two independent molecules exist in an asymmetric unit. 
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Chapter 3. Induced Au(I)-Au(I) interaction of dinuclear 
organogold(I) complexes with diphosphine ligands and uracil 
moieties 
3-1. Introduction 
As mentioned in the chapter 2, Au(I)-Au(I) interaction in the  gold(I) 
complexes is influenced by steric structure of ancillary ligands. The dinuclear gold(I) 
complex with a bridging ligand is conceived to be a useful approach for the design of 
well-designed aggregates.
1
 Arrangement of metal centers in the same side of the ligand 
is expected by using the semirigid bridging diphosphine ligand. Xantphos and 
(R)-BINAP were focused on as the bridging diphosphine ligand. The advantage in the 
use of Xantphos and (R)-BINAP derived from their semirigid backbone to arrange the 
phosphorus atoms on the same side. From these points of view, I herein report designs 
and syntheses of the dinuclear organogold(I)-uracil conjugates with the bridging 
diphosphine ligands in order to control the arrangement of Au(I) centers and 
self-assembly properties of the uracil moieties. 
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3-2. Result and discussion 
The dinuclear organogold(I)-uracil conjugates with the bridging diphosphine 
ligands were synthesized by the introduction of Xantphos and (R)-BINAP to cause an 
intramolecular aurophilic Au(I)-Au(I) interaction. The dinuclear organogold(I)-uracil 
conjugates (U6Au)2(-Xantphos), (U5Au)2(-Xantphos) and (U6Au)2(-R-BINAP) 
were obtained by the reaction of 6-ethynyl-1-octyluracil or 5-ethynyl-1-octyluracil with 
(ClAu)2(-diphosphine) (diphosphine = Xantphos or (R)-BINAP), which were produced 
by the treatment of chloro(tetrahydrothiophene)gold(I) [ClAu(tht)] with the 
corresponding diphosphine in situ, in the presence of sodium bis(trimethylsilyl)amide 
(Scheme 1). Thus-obtained dinuclear organogold(I)-uracil conjugates were fully 
confirmed by 
1
H NMR, 
13
C NMR, 
31
P NMR, IR, HRMS, and elemental analysis. In the 
1
H NMR spectra, the signal for the ethynyl proton of the uracil derivatives disappeared 
and the upfield shift of the uracil proton was observed after the introduction of the Au(I) 
center. The 
31
P NMR spectra of (U6Au)2(-Xantphos), (U5Au)2(-Xantphos) and 
(U6Au)2(-R-BINAP) exhibited only one kind of resonance at around 30 ppm in 
CD2Cl2, suggestng that two phosphorus atoms of the dinuclear organogold(I)-uracil 
conjugates are equivalent in NMR time scale. 
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Scheme 1. 
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X-ray crystallographic analyses were performed in order to elucidate the 
coordination environment of Au(I) centers and self-assembly properties of the dinuclear 
organogold(I)-uracil conjugates. Diffraction-quality single crystals of 
(U6Au)2(-Xantphos) and (U5Au)2(-Xantphos) were prepared by diffusion of 
methanol into dichloromethane solution of (U6Au)2(-Xantphos) and diffusion of 
hexane into dichloromethane solution of (U5Au)2(-Xantphos). The dinuclear structure 
of (U6Au)2(-Xantphos) bearing 6-ethynyl-1-octyluracil moiety was determined by 
single-crystal X-ray structure determination (Figure 1). The crystal structure showed a 
linear coordination geometry of the Au(I) centers bridged by Xantphos ligand. It is a 
noteworthy that an intramolecular aurophilic Au(I)-Au(I) interaction was observed with 
Au(1)-Au(2) distance of 2.9994(8) Å. The semirigid xanthene backbone was found to 
facilitate the arrangement of the phosphorus atoms on the same side to induce 
intramolecular Au(I)-Au(I) interaction. The conformational enantiomers based on the 
torsional twist about the Au(I)-Au(I) axis are possible in the dinuclear gold(I)-uracil 
conjugates (Figure 2). The dinuclear organogold(I) complex (U6Au)2(-Xantphos) 
crystallized in the space group P-1 with R- and S-enantiomers based on the Au(I)-Au(I) 
axis in the unit cell (Figures 1a). The Au(I)-Au(I) interaction was found to induce the 
deviation from the linearity of the coordination structures of the Au centers with P-Au-C 
angles of 168.1(4)° and 174.5(5)°. The torsion angle of P(1)-Au(1)-Au(2)-P(2) of 82° 
indicates that the P-Au-C moieties are almost perpendicular to each other. Furthermore, 
the heterochiral hydrogen-bonded assembly was formed by connecting the each 
enantiomer alternately through intermolecular hydrogen bonds between the uracil 
moieties (Figure 1b and Table 1). There are two types of hydrogen bonding pattern in 
the heterochiral hydrogen bonded assembly, wherein one uracil moiety is linked by the 
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hydrogen bonded bridges of methanol solvent molecules and another uracil moiety is 
linked by hydrogen-bonded to the uracil moiety of another molecule directly (Figure 
1b). 
 
 
 
Figure 1. (a) Molecular structures of the R- and S-enantiomers of the dinuclear 
organogold(I)-uracil conjugates (U6Au)2(-Xantphos), (b) the heterochiral 
hydrogen-bonded assembly through intermolecular hydrogen bonds between the uracil 
moieties of (U6Au)2(-Xantphos) and (c) a part of the crystal structure showing two 
types of the hydrogen bonding pattern in the heterochiral hydrogen-bonded assembly 
(hydrogen atoms and octyl moieties are omitted for clarity). 
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Figure 2. Enantiomorphous conformations of the dinuclear organogold(I)-uracil 
conjugates with the bridging diphosphine ligands by . The enantiomorphs are related by 
the mirror plane. 
 
Table 1. Intermolecular hydrogen bonds for (U6Au)2(-Xantphos), U5Au)2(-Xantphos) 
and (U6Au)2(-R-BINAP) 
Compounds Donor Acceptor D•••A (Å) DH•••A (°) 
     (U6Au)2(-Xantphos) O(4)
a
 O(2)
b
 2.73(2) 147(10) 
 
N(2) O(4)
a
 2.78(2) 172(5) 
 
N(42) O(41)
c
 2.798(15) 167(4) 
     
(U5Au)2(-Xantphos) N(2) O(42)
d
 2.816(13) 166(4) 
 
N(42) O(1)
e
 2.924(13) 169(3) 
     
(U6Au)2(-R-BINAP) N(2) O(41)
f
 2.816(17) 158(4) 
 
N(42) O(2)
g
 2.789(18) 176(4) 
     (a) Oxygen atom of methanol. (b) X+2, Y+1, Z+2. (c) X+2, Y+1, Z+1. (d) X, Y, Z+1/2. 
(e) X, Y, Z+1/21. (f) X+2, Y+1/21, Z+1/2. (g) X+2, Y+1/2, Z+1/2.
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In the crystal structure of (U5Au)2(-Xantphos) composed of 
5-ethynyl-1-octyluracil, wherein the direction of hydrogen bonding sites of the uracil 
moieties is different from (U6Au)2(-Xantphos), an intramolecular aurophilic 
Au(I)-Au(I) interaction with Au(1)-Au(2) distance of 2.9287(9) Å was also determined 
by single-crystal X-ray structure determination. R- and S-enantiomers based on 
Au(I)-Au(I) axis in (U5Au)2(-Xantphos) were present as depicted in Figure 3a. The 
distortion of the linear coordination geometry of the Au centers based on the 
Au(I)-Au(I) interaction was also observed, resulting in P-Au-C angles of 166.9(3)° and 
176.1(3)°. Compared with (U6Au)2(-Xantphos), the P(1)-Au(1)-Au(2)-P(2) torsion 
angle of 78.96(10)° was slightly small. The Au-C bond of (U5Au)2(-Xantphos) was a 
little shorter than that of (U6Au)2(-Xantphos). The position of the introduced ethynyl 
moiety of the uracil is likely to influence the electronic environment of the Au centers. 
Interestingly, a homochiral  stacked dimer was formed through  interactions 
between the uracil moieties of each enantiomer (Figure 3b). Furthermore, each 
homochiral  stacked dimer was linked alternately for formation of the 
hydrogen-bonded assembly through intermolecular hydrogen bonds between the uracil 
moieties (Figure 3c and Table 1). The direction of hydrogen bonding sites were found to 
affect the self-assembly patterns. 
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Figure 3. (a) Molecular structures of the R- and S-enantiomers, (b) the homochiral 
stacked dimer, and (c) the heterochiral hydrogen-bonded assembly through 
intermolecular hydrogen bonds between the uracil moieties of the dinuclear 
organogold(I)-uracil conjugate (U5Au)2(-Xantphos) (hydrogen atoms and octyl 
moieties are omitted for clarity). 
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Based on the above-mentioned interesting results, we launched on the chirality 
induction in Au(I)-Au(I) axis by using the bridging diphosphine ligand with axial 
chirality. Diffraction-quality single crystal of (U6Au)2(-R-BINAP) was prepared by 
diffusion of hexane into chloroform solution of (U6Au)2(-R-BINAP). The dinuclear 
organogold(I)-uracil conjugate (U6Au)2(-R-BINAP) crystallized in the space group 
P212121; the molecular structure exhibited an intramolecular Au(I)-Au(I) interaction 
based on the aurophilic interaction (Figure 4). The deviation from the linear 
coordination structure of the Au centers with P-Au-C angles of 172.2(5)° and 176.5(4)° 
based on the Au(I)-Au(I) interaction was also observed. The crystal structure of 
(U6Au)2(-R-BINAP) showed the P(1)-Au(1)-Au(2)-P(2) torsion angle of 71.97(8)°, 
which is smaller than that of the gold(I)-uracil conjugates with Xantphos probably due 
to the difference for rigidity of the diphosphine frameworks. Gratifyingly, 
(U6Au)2(-R-BINAP) assumed R,R-configuration through the chirality induction in 
Au(I)-Au(I) axis by the axial chirality of BINAP moiety as shown in Figure 4a. 
Although Au(I)-Au(I) aurophilic interactions have been researched by using the 
bridging diphosphine ligand,
1
 to the best of our knowledge, the chirality induction in 
Au(I)-Au(I) axis has not been reported so far. In the crystal packing, a left-handed 
helical molecular arrangement was found to form by assembling of each molecule 
through intermolecular hydrogen bonds between the uracil moieties as shown in Figure 
4b. 
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Figure 4. (a) Molecular structure of the R-enantiomer and (b) the homochiral 
hydrogen-bonded assembly through intermolecular hydrogen bonds between the uracil 
moieties of the dinuclear organogold(I)-uracil conjugate (U6Au)2(-R-BINAP) 
(hydrogen atoms and octyl moieties are omitted for clarity). 
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3-3. Conclusions 
In conclusion, the combination of the dinuclear organogold(I) complexes with 
a bridging diphosphine ligand as an organometallic compound and the uracil derivative 
as a nucleobase was established to afford the bioorganometallic conjugates. The 
single-crystal X-ray structure determination of the dinuclear organogold(I)-uracil 
conjugates was demonstrated to disclose the assembly properties of the gold(I) and the 
uracil moieties in a solid state. The semirigid bridging diphosphine ligand was found to 
play an important role in the arrangement of the phosphorus atoms on the same side and 
to support the induction of intramolecular aurophilic Au(I)-Au(I) interaction, wherein R- 
and S-enantiomers based on Au(I)-Au(I) axis exist. It should be noted that the chirality 
of Au(I)-Au(I) axis was induced by the utilization of (R)-BINAP as the bridging 
diphosphine ligand with axial chirality. Their strong tendency to self-assemble through 
intermolecular hydrogen bonds between the uracil moieties is Interesting feature of the 
dinuclear organogold(I)-uracil conjugate. These hydrogen bonding patterns were found 
to depend on the direction of hydrogen bonding sites. 
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3-4. Experimental section 
General methods 
 All reagents and solvents were purchased from commercial sources and were 
further purified by the standard methods, if necessary. All manipulations were carried 
out under Ar. Infrared spectra were obtained with a JASCO FT/IR-6200 spectrometer. 
1
H, 
13
C, and 
31
P NMR spectra were recorded on a JNM-ECS 400 (400, 100 and 160 
MHz, respectively) spectrometer. For 
1
H and 
31
P NMR spectra, chemical shifts were 
determined by using of tetramethylsilane and 85% H3PO4 aq. as standard samples, 
respectively. Chemical shifts of 
13
C NMR spectra were determined relative to the 
solvent residual peaks. Mass spectra were run on a JEOL JMS-700 mass spectrometer. 
 6-Ethynyl-1-octyluracil,
2
 5-ethynyl-1-octyluracil,
3
 and 
chloro(tetrahydrothiophene)gold(I) [ClAu(tht)]
4
 were prepared by the literature 
methods. 
 
Synthesis of the dinuclear organogold(I)-uracil conjugate (U6Au)2(-Xantphos) 
 A mixture of Xantphos (116 mg, 0.20 mmol), 
chloro(tetrahydrothiophene)gold(I) (128 mg, 0.40 mmol), and 6-ethynyl-1-octyluracil 
(1) (100 mg, 0.40 mmol) was stirred in THF (20 mL) at room temperature for 10 
minutes under Ar. To the solution was added sodium bis(trimethylsilyl)amide (93 mg, 
0.51 mmol) and the resulting solution was stirred at room temperature under Ar for 12 h. 
The mixture was diluted with dichloromethane, washed with water, brine, and then 
dried over Na2SO4. The solvent was evaporated and the residue was washed with ethyl 
acetate. The crude product was purified by recrystallization from dichloromethane and 
methanol to afford the desired dinuclear organogold(I)-uracil conjugate 
60 
 
(U6Au)2(-Xantphos) (153 mg, 0.10 mmol) as a colorless crystal. 
 (U6Au)2(-Xantphos): yield 52%; IR (KBr) 3172, 3047, 2925, 2854, 2119, 
1677, 1579, 1435, 1403, 1363, 1227 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 5.0 x 10
3
 M): 
 8.22 (br, 2H), 7.69 (dd, 2H, J = 7.8, 1.4 Hz), 7.48-7.44 (m, 4H), 7.34-7.23 (m, 16H), 
7.11 (td, 2H, J = 7.8 Hz, 
4
JH-P = 1.2 Hz), 6.48 (ddd, 2H, J = 7.8, 1.4 Hz, 
3
JH-P = 12.1 Hz), 
5.67 (s, 2H), 4.01 (t, 4H, J = 7.2 Hz), 1.69 (s, 6H), 1.67-1.60 (m, 4H), 1.29-1.12 (m, 
20H), 0.81 (t, 6H, J = 6.8 Hz); 
13
C NMR (100 MHz, CD2Cl2, 5.0 x 10
3
 M): 163, 153 (d, 
2
JC-P = 4.0 Hz), 151.3, 150.2 (d, 
2
JC-P = 140.9 Hz),140.8, 134.6 (d, 
2
JC-P = 14.9 Hz), 
133.4, 132, 130, 129.8 (d, 
1
JC-P = 51.8 Hz), 129.5 (d, 
3
JC-P = 12 Hz), 124.9 (d, 
3
JC-P = 9.1 
Hz), 117 (d, 
1
JC-P = 52.2 Hz), 104.8, 95.5 (d, 
3
JC-P = 26.8 Hz), 46.6, 35.1, 32.2, 31.6, 
29.8, 29.6, 29.2, 27.1, 23, 14.2 ppm; 
31
P NMR (160 MHz, CD2Cl2, 5.0 x 10
3
 M): 31.2 
ppm; HRMS (FAB) m/z Calcd. for C67H71N4O5P2Au2 (M + H
+
), 1467.4225; Found, 
1467.4215; Anal. Calcd. for C67H70N4O5P2Au2: C, 54.85; H, 4.81; N, 3.82. Found: C, 
54.85; H, 4.94; N, 3.82. 
 
Synthesis of the dinuclear organogold(I)-uracil conjugate (U5Au)2(-Xantphos) 
 A mixture of Xantphos (58 mg, 0.10 mmol), 
chloro(tetrahydrothiophene)gold(I) (64 mg, 0.20 mmol), and 5-ethynyl-1-octyluracil (2) 
(50 mg, 0.40 mmol) was stirred in THF (10 mL) at room temperature for 10 minutes 
under Ar. To the solution was added sodium bis(trimethylsilyl)amide (47 mg, 0.25 
mmol) and the resulting solution was stirred at room temperature under Ar for 19 h. The 
mixture was diluted with dichloromethane, washed with water, brine, and then dried 
over Na2SO4. The solvent was evaporated and purification of the crude product by 
preparative thin-layer chromatography using dichloromethane/methanol (93:7 v/v) as 
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mobile phase gave the desired dinuclear organogold(I)-uracil conjugate 
(U5Au)2(-Xantphos) (20 mg, 0.014 mmol). Recrystallization from dichloromethane 
and hexane produced a yellow crystal. 
 (U5Au)2(-Xantphos): yield 14%; IR (KBr) 3178, 3053, 2925, 2854, 2116, 
1682, 1435, 1403, 1343, 1221 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 5.0 x 10
3
 M):  8.15 
(br, 2H), 7.66 (d, 2H, J = 7.7 Hz), 7.45-7.41 (m, 6H), 7.36-7.27 (m, 16H), 7.09 (t, 2H, J 
= 7.7 Hz), 6.49 (dd, 2H, J = 7.7 Hz, 
2
JH-P = 11.4 Hz), 3.66 (t, 4H, J = 7.3 Hz), 1.69-1.60 
(m, 10H), 1.33-1.22 (m, 20H), 0.87 (t, 6H, J = 6.8 Hz); 
13
C NMR (100 MHz, CD2Cl2, 
5.0 x 10
3
 M): 162.8, 153.1 (d, 
2
JC-P = 2.0 Hz), 151.1, 146.1, 137.5 (d, 
2
JC-P = 141.6 Hz), 
134.8 (d, 
2
JC-P = 14.5 Hz), 133.3, 132, 131.5, 130.7(d, 
1
JC-P = 55.8 Hz), 129.6, 129.3 (d, 
3
JC-P =11.4 Hz), 124.6 (d, 
3
JC-P = 8.1 Hz) 117.8 (d, 
1
JC-P = 50.5 Hz), 102.3, 94.6 (d, 
3
JC-P 
= 28.6 Hz), 49.1, 35, 32.1, 31.4, 29.5, 29.4, 26.7, 23, 14.2 ppm; 
31
P NMR (160 MHz, 
CD2Cl2, 5.0 x 10
3
 M): 31.8 ppm; HRMS (FAB) m/z Calcd. for C67H71N4O5P2Au2 (M + 
H
+
), 1467.4225; Found, 1467.4171. 
 
Synthesis of the dinuclear organogold(I)-uracil conjugate (U6Au)2(-R-BINAP) 
 A mixture of (R)-BINAP (125 mg, 0.20 mmol), 
chloro(tetrahydrothiophene)gold(I) (128 mg, 0.40 mmol), and 6-ethynyl-1-octyluracil 
(1) (99 mg, 0.20 mmol) was stirred in THF (20 mL) at room temperature for 20 minutes 
under Ar. To the solution was added sodium bis(trimethylsilyl)amide (93 mg, 0.51 
mmol) and the resulting solution was stirred at room temperature under Ar for 19 h. The 
mixture was diluted with dichloromethane, washed with water, brine, and then dried 
over Na2SO4. The solvent was evaporated and purification of the crude product by 
preparative thin-layer chromatography using dichloromethane/methanol (93:7 v/v) as 
62 
 
mobile phase gave the desired dinuclear organogold(I)-uracil conjugate 
(U6Au)2(-R-BINAP) (121 mg, 0.080 mmol). Recrystallization from chloroform, 
diethyl ether and hexane produced a pale yellow crystal. 
 (U6Au)2(-R-BINAP): yield 40%; IR (KBr) 3165, 3049, 2925, 2853, 2118, 
1683, 1582, 1456, 1407, 1367 cm
1
; 
1
H NMR (400 MHz, CD2Cl2, 1.0 x 10
2
 M):  8.69 
(br, 2H), 8.11 (d, 2H, J = 8.8 Hz), 7.93 (d, 2H, J = 8.2 Hz), 7.76-7.71 (m, 4H), 7.59 (t, 
2H, J = 8.8 Hz, 
3
JH-P = 8.8 Hz), 7.49-7.36 (m, 10H), 7.25-7.17 (m, 8H), 6.87-6.83 (m, 
2H), 6.60 (d, 2H, J = 8.5 Hz), 5.65 (s, 2H), 4.01-3.90 (m, 4H), 1.68-1.60 (m, 4H), 
1.34-1.14 (m, 20H), 0.83 (t, 6H, J = 6.8 Hz); 
13
C NMR (100 MHz, CD2Cl2, 1.0 x 10
2
 
M): 163.3, 152.1 (d, 
2
JC-P = 141.9 Hz), 151.4, 143.3 (dd, 
2
JC-P = 16 Hz, 
3
JC-P = 7.2 Hz), 
140.7 (d, 
4
JC-P = 2.6 Hz), 135.3 (d, 
2
JC-P = 14 Hz), 135, 134.8 (d, 
2
JC-P = 14.6 Hz), 134.1 
(d, 
3
JC-P = 10 Hz), 131.8, 130.5 (d, 
3
JC-P = 4.8 Hz), 130.4 (d, 
1
JC-P = 56.6 Hz), 130.2 (d, 
2
JC-P = 8.4 Hz), 129.5 (d, 
3
JC-P = 11.5 Hz), 129.3 (d, 
3
JC-P = 11.7 Hz), 128.9 (d, 
1
JC-P = 
56.6 Hz), 128.8, 128.6, 128.2 (d, 
1
JC-P = 56.2 Hz), 127.4, 127.3, 105.1, 93.2 (d, 
3
JC-P = 
25.9 Hz), 46.6, 32.2, 29.8, 29.7, 29.1, 27.1, 23, 14.2 ppm; 
31
P NMR (160 MHz, CD2Cl2, 
1.0 x 10
2
 M): 33.5 ppm; HRMS (FAB) m/z Calcd. for C72H71N4O4P2Au2 (M + H
+
), 
1511.4276; Found, 1511.4257; Anal. Calcd. for C72H70N4O4P2Au2•CHCl3: C, 53.77; H, 
4.39; N, 3.44. Found: C, 53.78; H, 4.45; N, 3.42. 
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X-ray structure analysis 
 All measurements for (U6Au)2(-Xantphos), (U5Au)2(-Xantphos), and 
(U6Au)2(-R-BINAP) were made on a Rigaku R-AXIS RAPID diffractometer using 
graphite monochromated MoK radiation. The structures of (U6Au)2(-Xantphos), 
(U5Au)2(-Xantphos), and (U6Au)2(-R-BINAP) were solved by direct methods
5
 and 
expanded using Fourier techniques. All calculations were performed using the 
CrystalStructure crystallographic software package
6
 except for the refinement, which 
was performed using SHELXL-97.
7
 The non-hydrogen atoms were refined 
anisotropically. The H atoms involved in hydrogen bonding were located in electron 
density maps. The remainder of the H atoms were placed in idealized positions and 
allowed to ride with the C atoms to which each was bonded. Crystallographic details are 
given in Table 2. Selected bond distances and angles are reported in Table 3. 
Crystallographic data (excluding structure factors) for the structures reported in this 
paper have been deposited with the Cambridge Crystallographic Data Centre as 
supplementary publication no. CCDC-1033826 for (U6Au)2(-Xantphos), 
CCDC-1033825 for (U5Au)2(-Xantphos) and CCDC-1033824 for 
(U6Au)2(-R-BINAP). Copies of the data can be obtained free of charge on application 
to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [Fax: (internat.) 
+44-1223/336-033; E-mail: deposit@ccdc.cam.ac.uk]. 
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Table 2. Crystallographic data for (U6Au)2(-Xantphos), (U5Au)2(-Xantphos) and 
(U6Au)2(-R-BINAP) 
 
(U6Au)2(-Xantphos) (U5Au)2(-Xantphos) (U6Au)2(-R-BINAP) 
    
Formula 
C67H70N4O5P2Au2 
・CH2Cl2 ・CH3OH 
C67H70N4O5P2Au2 
・CH2Cl2 
C72H70N4O4P2Au2 
・CHCl3 
Molecular weight 1584.17 1552.13 1630.63 
Crystal system Triclinic Monoclinic Orthorhombic 
Space group P1 (No. 2) C2/c (No. 15) P212121 (No. 19) 
a (Å) 10.6798(6) 30.3688(18) 11.0678(16) 
b (Å) 14.2920(7) 26.6704(15) 23.228(4) 
c (Å) 22.3083(13) 21.7986(12) 27.246(4) 
 (°) 97.4663(16) 
  
 (°) 90.7906(16) 109.0564(16) 
 
(°) 91.1556(14) 
  
V (Å
3
) 3375.0(3) 16688.2(16) 7004.5(18) 
Z 2 8 4 
Dcalcd (g cm
-3
) 1.559 1.235 1.546 
 (Mo K) (cm
-1
) 45.360  36.672 44.086 
T (°C) 4.0  4.0  150 
 (Mo K) (Å) 0.71075 0.71075 0.71075 
R1
a
 0.083 0.054 0.078  
wR2
b
 0.232 0.179 0.211 
    (a) R1 = ||Fo| |Fc|| / |Fo|. (b) wR2 = [w(Fo
2 
Fc
2
)
2 
/ w(Fo
2
)
2
]
1/2
. 
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Table 3. Selected bond distances (Å) and angles (°) for (U6Au)2(-Xantphos),  
(U5Au)2(-Xantphos) and (U6Au)2(-R-BINAP) 
 
(U6Au)2(-Xantphos) (U5Au)2(-Xantphos) (U6Au)2(-R-BINAP) 
    Bond distances (Å) 
   
Au(1)Au(2) 2.9994(8) 2.9286(5) 3.0021(9) 
Au(1)P(1) 2.283(4) 2.281(3) 2.281(4) 
Au(2)P(2) 2.275(3) 2.253(4) 2.290(4) 
Au(1)C(14) 2.009(14) 1.976(10) 2.066(14) 
Au(2)C(54) 2.002(17) 1.926(11) 2.003(17) 
C(13)C(14) 1.16(2) 1.230(13) 1.14(2) 
C(53)C(54) 1.18(2) 1.188(17) 1.16(2) 
    
Bond angles (°) 
   
P(1)Au(1)C(14) 168.1(4) 166.9(3) 172.2(5) 
P(2)Au(2)C(54) 174.5(5) 176.1(3) 176.5(4) 
Au(1)C(14)C(13) 180.0(13) 175.1(11) 175.8(14) 
Au(2)C(54)C(53) 173.1(16) 170.5(8) 175.6(14) 
C(4)C(13)C(14) 173.3(17) 
 
168.7(18) 
C(44)C(53)C(54) 173(2) 
 
175.3(18) 
C(3)C(13)C(14) 
 
171.6(13) 
 
C(43)C(53)C(54) 
 
175.9(10) 
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Conclusion 
In this dissertation, the synthesis of bioorganometallic compounds combined the 
organoplatinum(II) and organogold(I) complexes with the uracil and appearance of 
metal-metal interaction in the organometal-uracil conjugates is described. The structural 
characteristics and assembly properties of the organometal-uracil conjugates were 
determined by single-crystal X-ray structure determination, absorption and emission 
spectra and NMR measurement. Noncovalent bonds such as the hydrogen bonding and 
 interaction found to play an important role in aggregation of metal moieties and 
introduction of metal-metal interaction. These organometal-nucleobase conjugates are 
considered to have potential as probes, catalyst and pharmacy. 
 
In chapter 1, the bioorganometallic platinum(II) compounds were synthesized by 
the reaction of the corresponding uracil derivative with the organoplatinum(II) 
compound. the platinum(II) complex bearing 6-ethynyl-1-octyluracil revealed the 
formation of the Pt(II)-Pt(II) interaction by supporting of intermolecular hydrogen 
bonding between the uracil moieties and  interaction between the phenylbipyridine 
ligands. Furthermore, controlled arrangement of organoplatinum(II) complexes bearing 
uracil moieties was achieved by changing molecular scaffolds, which having two 
2,6-dihexamidopyridine moieties as a complementary hydrogen bonding site for the 
uracil moiety. The emission properties of the organoplatinum(II) compounds were tuned 
by the induced Pt(II)-Pt(II) and  interactions through the regulation of the 
aggregated structures.  
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In chapter 2, the conjugation of the gold(I) complex having a planar ligand or a 
bulky ligand with 6-ethynyl-1-octyluracil afforded the corresponding gold(I) complexes, 
respectively. The crystal structure of the gold(I)-urcil conjugate having the planar 
phenyl isocyanide ligand disclosed the formation of a head-to-tail dimer through the 
Au(I)-Au(I) and  interactions between the uracil and benzene moieties of phenyl 
isocyanide. Furthermore, each head-to-tail dimer was connected not only through the 
intermolecular hydrogen bonds of N-H•••O pattern between the uracil moieties but the 
weak hydrogen bonds of C-H•••O pattern between the uracil and benzene moieties of 
phenyl isocyanide. In contrast, the Au(I)-Au(I) interaction was not observed in a crystal 
structure of the gold(I)-uracil conjugate having the bulky triphenylphosphine ligand 
probably due to the steric hindrance of the bulky ligand 
 
In chapter 3, the dinuclear gold(I)-uracil conjugates synthesized by the 
treatment of the dinuclear organogold(I) complexes with a bridging 
diphosphine ligand and the uracil derivative. The crystal structure of the 
dinuclear gold(I)-uracil conjugates with Xantphos as a bridging diphosphine ligand 
exhibited an intramolecular aurophilic Au(I)-Au(I) interaction. R- and S-enantiomers 
based on Au(I)-Au(I) axis are exist in the unit cell. By contrast, the utilization of 
(R)-BINAP as the bridging diphosphine ligand with axial chirality was performed to 
induce the chirality of Au(I)-Au(I) axis. The crystal structure of the dinuclear 
organogold(I) complex with (R)-BINAP confirmed the axial chirality in Au(I)-Au(I) 
axis to form R,R-enantiomer, wherein each molecule is arranged through intermolecular 
hydrogen bonds between the uracil moieties to form a helical molecular arrangement. 
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The structure characterization and assembly properties of the bioorganometallic 
compounds bearing the uracil moieties were demonstrated to be controlled by the 
molecular scaffolds or ancillary ligands. These results and findings provide a significant 
contribution for structural control of metal-metal interaction in bioorganometallic 
compounds. 
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